Integer (NYSE:ITGR) PT Raised to $130.00 at Citigroup

Integer (NYSE:ITGR) had its price objective lifted by Citigroup from $124.00 to $130.00 in a report published on Tuesday morning, Benzinga reports. The brokerage currently has a neutral rating on the medical equipment provider’s stock.

Other equities analysts have also issued reports about the stock. Oppenheimer began coverage on shares of Integer in a research report on Tuesday, July 16th. They set an outperform rating and a $135.00 target price on the stock. Benchmark restated a buy rating and set a $130.00 target price on shares of Integer in a research report on Friday, August 2nd. Bank of America raised their target price on shares of Integer from $135.00 to $145.00 and gave the stock a buy rating in a research report on Tuesday. Finally, Truist Financial raised their target price on shares of Integer from $137.00 to $145.00 and gave the stock a buy rating in a research report on Tuesday. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of Moderate Buy and an average price target of $137.29.

Integer Stock Down 1.1 %

ITGR stock opened at $125.81 on Tuesday. The company’s 50 day moving average price is $123.63 and its 200 day moving average price is $119.41. The company has a debt-to-equity ratio of 0.73, a quick ratio of 1.96 and a current ratio of 3.29. Integer has a fifty-two week low of $69.40 and a fifty-two week high of $131.87. The firm has a market capitalization of $4.22 billion, a price-to-earnings ratio of 43.53, a PEG ratio of 1.87 and a beta of 1.09.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, July 25th. The medical equipment provider reported $1.30 EPS for the quarter, beating the consensus estimate of $1.24 by $0.06. The company had revenue of $436.20 million for the quarter, compared to analyst estimates of $437.00 million. Integer had a net margin of 6.31% and a return on equity of 11.48%. The firm’s revenue was up 9.0% on a year-over-year basis. During the same period in the prior year, the firm posted $1.14 earnings per share. On average, equities research analysts anticipate that Integer will post 5.31 EPS for the current fiscal year.

Insider Buying and Selling at Integer

In other news, Director Jean M. Hobby sold 11,960 shares of Integer stock in a transaction dated Wednesday, July 31st. The stock was sold at an average price of $119.66, for a total value of $1,431,133.60. Following the transaction, the director now directly owns 2,280 shares of the company’s stock, valued at approximately $272,824.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 2.00% of the stock is owned by company insiders.

Institutional Investors Weigh In On Integer

Institutional investors have recently made changes to their positions in the company. Vanguard Group Inc. boosted its position in Integer by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock worth $446,428,000 after acquiring an additional 23,382 shares during the period. Earnest Partners LLC lifted its holdings in shares of Integer by 3.2% in the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after buying an additional 37,340 shares during the period. Congress Asset Management Co. MA lifted its holdings in shares of Integer by 7.5% in the first quarter. Congress Asset Management Co. MA now owns 453,260 shares of the medical equipment provider’s stock valued at $52,886,000 after buying an additional 31,736 shares during the period. Driehaus Capital Management LLC lifted its holdings in shares of Integer by 62.5% in the second quarter. Driehaus Capital Management LLC now owns 353,052 shares of the medical equipment provider’s stock valued at $40,880,000 after buying an additional 135,750 shares during the period. Finally, Tributary Capital Management LLC lifted its holdings in shares of Integer by 0.3% in the second quarter. Tributary Capital Management LLC now owns 286,449 shares of the medical equipment provider’s stock valued at $33,168,000 after buying an additional 772 shares during the period. 99.29% of the stock is currently owned by institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.